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Neisseria gonorrhoeae, the etiological agent that causes the sexually transmitted infection gonorrhea, is a significant public
health concern due to the emergence of antimicrobial resistance. We report the complete genome sequences of three reference
isolates with varied antimicrobial susceptibility that will aid in elucidating the genetic mechanisms that confer resistance.
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Neisseria gonorrhoeae is a Gram-negative, betaproteobacteriumthat is the etiological agent responsible for the sexually trans-
mitted infection gonorrhea. In 2008, the World Health Organiza-
tion estimated 106 million new gonorrhea cases worldwide (1),
and the Centers for Disease Control and Prevention (CDC) re-
ported over 300,000 cases in 2012, making it the second most
common notifiable infection in the United States (2). The emer-
gence of gonococcal resistance to former first-line antibiotics (e.g.,
penicillins, tetracyclines, fluoroquinolones, and cephalosporins)
has been facilitated by both plasmid- and chromosome-mediated
mechanisms (3). In response to the recent emergence of decreased
susceptibility to third-generation cephalosporins, the CDC cur-
rently recommends the dual-use of ceftriaxone with either azi-
thromycin or doxycycline as treatment for uncomplicated gonor-
rhea (4).
To better understand the mechanisms associated with antibi-
otic resistance, we sequenced the complete genomes of three lab-
oratory reference strains with varying degrees of antibiotic suscep-
tibility. Gonococcal strain FA19 is a wild-type strain that was
isolated in 1962 from a patient with a disseminated gonococcal
infection, and is highly susceptible to penicillin, tetracycline,
erythromycin, chloramphenicol, and rifampin (5) (https://www
.broadinstitute.org/annotation/genome/neisseria_gonorrhoeae
/GenomeDescriptions.html#Strain_fa19). Strain FA6140 was iso-
lated in 1983 from an outbreak of penicillin-resistant gonorrhea in
Durham, NC, and it exhibits chromosomally mediated resistance
to penicillin, tetracycline, and erythromycin (6). Lastly, strain
35/02 was isolated in 2002 in Sweden, and it exhibits chromo-
somally mediated resistance to penicillin and reduced susceptibil-
ity to the extended-spectrum cephalosporins, cefixime and ceftri-
axone (7). Moreover, 35/02 also contains a mosaic penA allele with
58 mutations relative to the penA gene from FA19 (7); mosaic
penA alleles are strongly associated with reduced cefixime and
ceftriaxone susceptibility in clinical samples (8).
Whole-genome sequencing was conducted using the PacBio
RSII platform (Pacific Biosciences, Menlo Park, CA) with P5-C3
chemistry. A single single-molecule real-time (SMRT) cell was
used to sequence FA19 (mean coverage of 119-fold), while
FA6140 and 35/02 were each sequenced using two SMRT cells
(mean coverage of 309-fold and 262-fold, respectively). De novo
assembly of the genomes was conducted using the hierarchical
genome assembly process (HGAP3, SMRTAnalysis 2.3.0) work-
flow, which included consensus polishing using Quiver (9). Sin-
gle, closed contigs were assembled for each sequence, and the fol-
lowing genome length and GC content data were obtained:
FA19 (2,232,367 bp, 52.4% GC content), FA6140 (2,168,698 bp,
52.6% GC content), and 35/02 (2,173,235 bp, 52.6% GC con-
tent). The genomes were annotated using Prokka version 1.11
(10), and a total of 2,289, 2,230, and 2,228 coding sequences were
annotated in FA19, FA6140, and 35/02, respectively. A compara-
tive analysis of these genomes will be reported in a future publi-
cation.
Nucleotide sequence accession numbers. The complete ge-
nome sequences for N. gonorrhoeae strains FA19, FA6140, and
35/02 have been deposited in GenBank under the accession num-
bers CP012026, CP012027, and CP012028, respectively.
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